BIOMAT Database Logo BIOMAT Database Logo

Combination therapy with methotrexate and chloroquine in rheumatoid arthritis. A multicenter randomized placebo-controlled trial. 1994

M B Ferraz, and G R Pinheiro, and M Helfenstein, and E Albuquerque, and C Rezende, and L Roimicher, and L Brandao, and S C Silva, and G C Pinheiro, and E Atra
Escola Paulista de Medicina, Disciplina de Reumatologia, Sao Paulo, Brazil.

To compare the efficacy of the combination therapy Methotrexate (MTX) and Chloroquine (CHLO) with MTX and Placebo (PLA) in the treatment of Rheumatoid Arthritis. A total of 82 patients with Rheumatoid Arthritis (RA), diagnosed according to the American College of Rheumatology criteria, received orally either MTX 7.5 mg/week and CHLO 250 mg/day or MTX 7.5 mg/week and PLA 1 tablet/day. Adverse effects (AE) were monitored monthly and disease activity was assessed at 0, 2, 4 and 6 months. Sixty-eight patients completed the study. All outcome measures improved significantly in both treatment groups. Patients receiving MTX/CHLO ended the study with a significantly lower joint count, greater grip strength and better functional ability the patients in the MTX/PLA group, respectively; 4.5 vs 7.5 (P < 0.05), 113.3 vs 89.1 (P < 0.05) and 0.636 vs 0.811 (P < 0.05). Mild AE were more frequently observed in the MTX/CHLO, 17 events in 15 patients, compared to 9 events in 8 patients in the MTX/PLA group (NS). These data indicate that MTX/CHLO is slightly more efficacious and toxic than is MTX/PLA in the treatment of RA.

UI MeSH Term Description Entries
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002738 Chloroquine The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses. Aralen,Arechine,Arequin,Chingamin,Chlorochin,Chloroquine Sulfate,Chloroquine Sulphate,Khingamin,Nivaquine,Sulfate, Chloroquine,Sulphate, Chloroquine
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

M B Ferraz, and G R Pinheiro, and M Helfenstein, and E Albuquerque, and C Rezende, and L Roimicher, and L Brandao, and S C Silva, and G C Pinheiro, and E Atra
Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial.
November 2004, Arthritis and rheumatism,
M B Ferraz, and G R Pinheiro, and M Helfenstein, and E Albuquerque, and C Rezende, and L Roimicher, and L Brandao, and S C Silva, and G C Pinheiro, and E Atra
A multicenter, double-blind, randomized, placebo controlled trial of infliximab combined with low dose methotrexate in Japanese patients with rheumatoid arthritis.
January 2006, The Journal of rheumatology,
M B Ferraz, and G R Pinheiro, and M Helfenstein, and E Albuquerque, and C Rezende, and L Roimicher, and L Brandao, and S C Silva, and G C Pinheiro, and E Atra
A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study.
May 2005, Arthritis and rheumatism,
M B Ferraz, and G R Pinheiro, and M Helfenstein, and E Albuquerque, and C Rezende, and L Roimicher, and L Brandao, and S C Silva, and G C Pinheiro, and E Atra
A randomized placebo-controlled trial of methotrexate in psoriatic arthritis.
August 2012, Rheumatology (Oxford, England),
M B Ferraz, and G R Pinheiro, and M Helfenstein, and E Albuquerque, and C Rezende, and L Roimicher, and L Brandao, and S C Silva, and G C Pinheiro, and E Atra
Combination therapy with gold and hydroxychloroquine in rheumatoid arthritis: a prospective, randomized, placebo-controlled study.
April 1989, British journal of rheumatology,
M B Ferraz, and G R Pinheiro, and M Helfenstein, and E Albuquerque, and C Rezende, and L Roimicher, and L Brandao, and S C Silva, and G C Pinheiro, and E Atra
Comparison of combination therapy with methotrexate and sinomenine or leflunomide for active rheumatoid arthritis: A randomized controlled clinical trial.
April 2019, Phytomedicine : international journal of phytotherapy and phytopharmacology,
M B Ferraz, and G R Pinheiro, and M Helfenstein, and E Albuquerque, and C Rezende, and L Roimicher, and L Brandao, and S C Silva, and G C Pinheiro, and E Atra
A randomized, double-blind, multicenter, controlled clinical trial of cyclosporine plus chloroquine vs. cyclosporine plus placebo in early-onset rheumatoid arthritis.
January 2004, Archives of medical research,
M B Ferraz, and G R Pinheiro, and M Helfenstein, and E Albuquerque, and C Rezende, and L Roimicher, and L Brandao, and S C Silva, and G C Pinheiro, and E Atra
Hydroxychloroquine compared with placebo in rheumatoid arthritis. A randomized controlled trial.
December 1993, Annals of internal medicine,
M B Ferraz, and G R Pinheiro, and M Helfenstein, and E Albuquerque, and C Rezende, and L Roimicher, and L Brandao, and S C Silva, and G C Pinheiro, and E Atra
Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial.
May 2007, Arthritis and rheumatism,
M B Ferraz, and G R Pinheiro, and M Helfenstein, and E Albuquerque, and C Rezende, and L Roimicher, and L Brandao, and S C Silva, and G C Pinheiro, and E Atra
A randomized, double blind, placebo controlled multicenter trial of murine anti-CD4 monoclonal antibody therapy in rheumatoid arthritis.
August 1998, The Journal of rheumatology,
Copied contents to your clipboard!